<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Parasitic helminths</title>
    <subTitle>targets, screens, drugs and vaccines</subTitle>
  </titleInfo>
  <name type="personal">
    <namePart>Caffrey, Conor R.</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <genre authority="">Electronic books.</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">gw</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Weinheim, Germany</placeTerm>
    </place>
    <publisher>Wiley-VCH</publisher>
    <dateIssued>2012</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <extent>1 online resource (xxiii, 516 pages :) : illustrations (some color).</extent>
  </physicalDescription>
  <tableOfContents>Part one: targets -- Ligand-gated ion channels as targets for anthelmintic drugs: past, current, and future perspectives -- How relevant is Caenorhabditis elegans as a model for the analysis of parasitic nematode biology? -- Integrating and mining helminth genomes to discover and prioritize novel therapeutic targets -- Recent progress in transcriptomics of key gastrointestinal nematodes of animals: fundamental research toward new intervention strategies -- Harnessing genomic technologies to explore the molecular biology of liver flukes-major implications for fundamental and applied research -- RNA interference: a potential discovery tool for therapeutic targets of parasitic nematodes -- RNA interference as a tool for drug discovery in parasitic flatworms -- Part two: screens -- Mechanism-based screening strategies for anthelmintic discovery -- Identification and profiling of nematicidal compounds in veterinary parasitology -- Quantitative high-content screening-based drug discovery against helmintic diseases -- Use of rodent models in the discovery of novel anthelmintics -- To kill a mocking worm: strategies to improve Caenorhabditis elegans as a model system for use in anthelmintic discovery -- Part three: drugs -- Anthelmintic drugs: tools and shortcuts for the long road from discovery to product -- Antinematodal drugs: modes of action and resistance: and worms will not come to thee (Shakespeare: Cymbeline: iv, ii) -- Drugs and targets to perturb the symbiosis of Wolbachia and filarial nematodes -- Promise of Bacillus thuringiensis crystal proteins as anthelmintics -- Monepantel: from discovery to mode of action -- Discovery, mode of action, and commercialization of derquantel -- Praziquantel: too good to be replaced? -- Drug discovery for trematodiases: challenges and progress -- Part four: vaccines -- Barefoot thru' the valley of darkness: preclinical development of a human hookworm vaccine -- Vaccines linked to chemotherapy: a new approach to control helminth infections -- Antifilarial vaccine development: present and future approaches -- Proteases as vaccines against gastrointestinal nematode parasites of sheep and cattle -- Schistosomiasis vaccines: new approaches to antigen discovery and promising new candidates -- Sm14 Schistosoma mansoni fatty acid-binding protein: molecular basis for an antihelminth vaccine -- Mechanisms of immune modulation by Fasciola hepatica: importance for vaccine development and for novel immunotherapeutics -- Prospects for immunoprophylaxis against Fasciola hepatica (liver fluke) -- Vaccines against cestode parasites.</tableOfContents>
  <note type="statement of responsibility">edited by Conor R. Caffrey.</note>
  <note>Includes bibliographical references and index.</note>
  <subject authority="lcsh">
    <topic>Helminths</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Parasites</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Parasitic diseases</topic>
    <topic>Treatment</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Parasitic diseases</topic>
    <topic>Diagnosis</topic>
  </subject>
  <subject authority="fast">
    <topic>Helminths</topic>
  </subject>
  <subject authority="fast">
    <topic>Parasites</topic>
  </subject>
  <subject authority="fast">
    <topic>Parasitic diseases</topic>
    <topic>Diagnosis</topic>
  </subject>
  <subject authority="fast">
    <topic>Parasitic diseases</topic>
    <topic>Treatment</topic>
  </subject>
  <classification authority="lcc">RC119.7 .P37 2012eb</classification>
  <classification authority="ddc" edition="23">616.96061</classification>
  <relatedItem type="series">
    <titleInfo>
      <title>Drug discovery in infectious diseases ; v. 3</title>
    </titleInfo>
  </relatedItem>
  <identifier type="isbn">9783527652969</identifier>
  <identifier type="isbn">3527652965</identifier>
  <identifier type="isbn">9783527652938</identifier>
  <identifier type="isbn">3527652930</identifier>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="uri">http://onlinelibrary.wiley.com/book/10.1002/9783527652969</identifier>
  <location>
    <url>http://onlinelibrary.wiley.com/book/10.1002/9783527652969</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">E7B</recordContentSource>
    <recordCreationDate encoding="marc">120713</recordCreationDate>
    <recordChangeDate encoding="iso8601">20170612141630.0</recordChangeDate>
    <recordIdentifier source="OCoLC">ocn802056669</recordIdentifier>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
